1075178-25-4

Basic information

• Product Name: 3-(3-bromophenyl)-3-hydroxypropanenitrile
• Synonyms: 3-(3-bromophenyl)-3-hydroxypropanenitrile
• CAS NO: 1075178-25-4
• Molecular Weight: 226.073
• Mol File: 1075178-25-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-(3-bromophenyl)-3-hydroxypropanenitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-bromophenyl)-3-hydroxypropanenitrile(1075178-25-4)
• EPA Substance Registry System: 3-(3-bromophenyl)-3-hydroxypropanenitrile(1075178-25-4)

Safety Data

• Hazardous Substances Data: 1075178-25-4(Hazardous Substances Data)

Upstream product

• 1798-85-2 1-bromo-3-cyclopropylbenzene 
• 3132-99-8 m-bromobenzoic aldehyde 
• 75-05-8 acetonitrile 

Downstream Products

• 1075178-40-3 (±)-3-amino-1-(3-bromophenyl)propan-1-ol 
• 1098107-78-8 (R)-2,2,2-trifluoro-N-(3-hydroxy-3-(3-(3-hydroxy-3-propylhex-1-ynyl)phenyl)propyl)acetamide 
• 1075178-41-4 N-(3-(3-bromophenyl)-3-hydroxypropyl)-2,2,2-trifluoroacetamide 
• 1098107-09-5 (±)-tert-butyl N-[3-(3-bromophenyl)-3-hydroxy-propyl]carbamate 
• 1098107-74-4 C₁₁H₉BrF₃NO₂ 
• 1374417-02-3 1-(3-bromophenyl)-1-hydroxyhex-5-en-3-one 
• 1374417-24-9 C₁₂H₁₁BrO 

Relevant articles and documents

Isomerization of 3-unsubstituted 4,5-dihydroisoxazoles over alumina. A new synthesis of β-hydroxy nitriles

3-Unsubstituted 4,5-dihydroisoxazoles obtained by nitrosation of arylcyclopropanes are capable of undergoing efficient isomerization into 3-aryl-3-hydroxypropanenitriles during chromatography on alumina.

COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.